Prontip Saelee is working on ground breaking research in the way of cancer treatment.
There's just one problem.
“It's just me," she said.
She's the only employee working for Tactiva Therapeutics. The Roswell Park Cancer Institute company takes a patient's own cancer-fighting white cells and stem cells, genetically modifies them to become super cells, and then injects them back into the patient's body to fight the cancerous cells.
“This is world class science being done here,” said Tactiva Co-Founder, Matt Colpoys.
The company’s ready to begin clinical trials. It's raised $35 million in private investments to grow the company. “If we had more people, it would be helpful in making the research move forward,” explained Saelee.
Colpoys said they have openings for lab technicians, research assistants, and office administrators. But, they're conducting a national search for higher level positions like the medical director.
7 Eyewitness News Reporter Ali Touhey: Do you think you won’t be able to find that locally?
Colpoys: There's nobody that has the background. These are MBA/PhD people with prior experience in the industry. Well, the industry doesn't exist in Buffalo, NY.
Tactiva will be hiring employees over the next 18 months. For more information, click here.
Have a news tip, question or comment?
Take WKBW Everywhere, on all your devices. Download below!
Phone or Tablet: Apple, Android
Set-top Device: Roku, Apple TV, Amazon Fire TV
Amazon Alexa
Personalize your news, get the latest 7 First Alert Forecast, and watch 7 Eyewitness News video wherever, whenever.
Learn more here about what 7 Eyewitness News provides on all these devices.
